Dr. John Jay Padre Cadavona, MD

Dr. Cadavona practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Cadavona's NPI, 1235627456, was assigned on April 24, 2018. Dr. Cadavona graduated from UNR Med in 2018. Dr. Cadavona holds California license A182763.

Dr. Cadavona's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Cadavona's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Cadavona is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cadavona practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cadavona's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Cadavona is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Cadavona's licenses on file in 2 states: California and Nevada.

Dmand AI lists acute diabetes, acute respiratory failure, bile duct problems, cardiac arrhythmia, congestive heart failure, electrolyte disorders, gastrointestinal inflammation and kidney failure among the conditions Dr. Cadavona treats.

CMS data shows 653 Medicare services from Dr. Cadavona across 5 procedure codes in 2024, for 220 Medicare patients. Medicare paid $59,666 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 220 Medicare patients who saw Dr. Cadavona in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cadavona's median patient age at 60, with 47% women.

In 2024, Dr. Cadavona wrote 139 Medicare Part D claims for 54 patients. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $122 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cadavona for performance year 2024, reported as part of a group. Dr. Cadavona accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Cadavona from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Hospital Products Inc. paid the most, $136.

Dr. Cadavona graduated from UNR Med in 2018.

Dr. Cadavona is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.